Munabi, Naikhoba C O <br/><br/>
Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.  [electronic resource] 

 -  Stem cells translational medicine  Jan 2016 
 - 45-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2157-6564 
<br/><br/><label>Standard No.: </label>10.5966/sctm.2015-0076  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Cell Proliferation--drug effects<br/>Cyclic AMP--metabolism<br/>Dose-Response Relationship, Drug<br/>Hemangioma--drug therapy<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Mice<br/>Mice, Nude<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3--metabolism<br/>Neoplasm Proteins--metabolism<br/>Neoplastic Stem Cells--metabolism<br/>Propranolol--pharmacology<br/>Receptors, Adrenergic, beta-1--metabolism<br/>Receptors, Adrenergic, beta-2--metabolism<br/>Xenograft Model Antitumor Assays